The companies run more than 90% of the nation’s drug and medical supply chain and have been accused of allowing the proliferation and abuse of prescription opioids.

The companies failed for more than a decade to track suspicious orders or increases in opioid use among purchasers, despite likely criminal activity from some physicians in overprescribing the drugs.